PERSPECTA

News from every angle

← Back to headlines

Bank of America Securities Maintains Buy Rating for Beam Therapeutics

Bank of America Securities has reiterated its 'Buy' rating for Beam Therapeutics (BEAM), signaling continued confidence in the biotechnology company's stock.

15 Jul, 14:01 — 15 Jul, 14:01
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual31d ago

Bank of America Securities Maintains Buy Rating for Beam Therapeutics (BEAM)

Read full article →

Related Stories

CAG Flags E. coli in Drinking Water at Indian Railway Stations

44m ago

Shah Rukh Khan, Ajay Devgn, Tiger Shroff Issued Notices Over Vimal Elaichi Ad

2h ago

Belgrade Businessman Arrested for Multi-Million Dollar Fraud

8h ago

Former Taco Bell CEO Criticizes McDonald's New Red Bull Drink

9h ago